Compare FULC & SPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FULC | SPT |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 707.9M | 651.7M |
| IPO Year | N/A | N/A |
| Metric | FULC | SPT |
|---|---|---|
| Price | $10.71 | $6.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 10 |
| Target Price | $16.38 | ★ $21.70 |
| AVG Volume (30 Days) | 592.5K | ★ 1.7M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $13.32 |
| Revenue Next Year | N/A | $11.23 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.32 | $6.52 |
| 52 Week High | $15.74 | $32.05 |
| Indicator | FULC | SPT |
|---|---|---|
| Relative Strength Index (RSI) | 52.04 | 28.08 |
| Support Level | $10.04 | $6.52 |
| Resistance Level | $11.17 | $7.37 |
| Average True Range (ATR) | 0.65 | 0.56 |
| MACD | 0.07 | -0.12 |
| Stochastic Oscillator | 75.28 | 14.79 |
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions.